Conference
Efficacy, pharmacokinetics (PK) and safety results of a phase 3 clinical study of recombinant fusion protein linking coagulation factor IX with albumin (RIX-FP) in previously treated children with hemophilia B
Authors
Kenet G; Chambost H; Male C; Lambert T; Alvarez-Roman M; Halimeh S; Chan A; Barnes C; Chernova T; Blatny J
Volume
13
Pagination
pp. 227-228
Publisher
WILEY-BLACKWELL
Publication Date
June 1, 2015
Conference proceedings
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
ISSN
1538-7933